enVVeno Medical Corp
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company's lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in … Read more
Market Cap & Net Worth: enVVeno Medical Corp (NVNO)
enVVeno Medical Corp (NASDAQ:NVNO) has a market capitalization of $7.21 Million ($7.21 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31464 globally and #10351 in its home market, demonstrating a -7.02% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying enVVeno Medical Corp's stock price $11.00 by its total outstanding shares 655000 (655.00K).
enVVeno Medical Corp Market Cap History: 2018 to 2026
enVVeno Medical Corp's market capitalization history from 2018 to 2026. Data shows change from $24.15 Million to $7.21 Million (-27.21% CAGR).
Index Memberships
enVVeno Medical Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #807 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2564 of 3165 |
Weight: enVVeno Medical Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
enVVeno Medical Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how enVVeno Medical Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
288.26x
enVVeno Medical Corp's market cap is 288.26 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $24.15 Million | $186.55K | -$13.04 Million | 129.47x | N/A |
| 2019 | $9.01 Million | $31.24K | -$7.63 Million | 288.26x | N/A |
Competitor Companies of NVNO by Market Capitalization
Companies near enVVeno Medical Corp in the global market cap rankings as of March 19, 2026.
Key companies related to enVVeno Medical Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
enVVeno Medical Corp Historical Marketcap From 2018 to 2026
Between 2018 and today, enVVeno Medical Corp's market cap moved from $24.15 Million to $ 7.21 Million, with a yearly change of -27.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $7.21 Million | +3328.93% |
| 2025 | $210.12K | -89.38% |
| 2024 | $1.98 Million | -41.25% |
| 2023 | $3.37 Million | +0.78% |
| 2022 | $3.34 Million | -22.61% |
| 2021 | $4.32 Million | -23.82% |
| 2020 | $5.67 Million | -37.09% |
| 2019 | $9.01 Million | -62.71% |
| 2018 | $24.15 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of enVVeno Medical Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.21 Million USD |
| MoneyControl | $7.21 Million USD |
| MarketWatch | $7.21 Million USD |
| marketcap.company | $7.21 Million USD |
| Reuters | $7.21 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.